Recombinant multi-species PTPRG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PTPRG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this PTP contains a carbonic anhydrase-like (CAH) domain, which is also found in the extracellular region of PTPRBETA/ZETA. This gene is located in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma, thus is thought to be a candidate tumor suppressor gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 5430405N12Rik,HPTPG,PTPG,PTPRG,Protein-tyrosine phosphatase gamma,Ptpg,Ptprg,R-PTP-GAMMA,R-PTP-gamma,RPTPG,RPTPgamma,Receptor-type tyrosine-protein phosphatase gamma

Target products collectionGo to PTPRG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1458-Ag-1/ GM-Tg-hg-IP1458-Ag-2 Human PTPRG protein Human
GM-Tg-rg-IP1458-Ag-1/ GM-Tg-rg-IP1458-Ag-2 Rat PTPRG protein Rat
GM-Tg-mg-IP1458-Ag-1/ GM-Tg-mg-IP1458-Ag-2 Mouse PTPRG protein Mouse
GM-Tg-cynog-IP1458-Ag-1/ GM-Tg-cynog-IP1458-Ag-2 Cynomolgus/Rhesus macaque PTPRG protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1458-Ag-1/ GM-Tg-felg-IP1458-Ag-2 Feline PTPRG protein Feline
GM-Tg-cang-IP1458-Ag-1/ GM-Tg-cang-IP1458-Ag-2 Canine PTPRG protein Canine
GM-Tg-bovg-IP1458-Ag-1/ GM-Tg-bovg-IP1458-Ag-2 Bovine PTPRG protein Bovine
GM-Tg-equg-IP1458-Ag-1/ GM-Tg-equg-IP1458-Ag-2 Equine PTPRG protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1458-Ag-1/ GM-Tg-hg-IP1458-Ag-2; GM-Tg-rg-IP1458-Ag-1/ GM-Tg-rg-IP1458-Ag-2;
GM-Tg-mg-IP1458-Ag-1/ GM-Tg-mg-IP1458-Ag-2; GM-Tg-cynog-IP1458-Ag-1/ GM-Tg-cynog-IP1458-Ag-2;
GM-Tg-felg-IP1458-Ag-1/ GM-Tg-felg-IP1458-Ag-2; GM-Tg-cang-IP1458-Ag-1/ GM-Tg-cang-IP1458-Ag-2;
GM-Tg-bovg-IP1458-Ag-1/ GM-Tg-bovg-IP1458-Ag-2; GM-Tg-equg-IP1458-Ag-1/ GM-Tg-equg-IP1458-Ag-2
Products Name PTPRG protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PTPRG
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PTPRG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.